Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Juanzhi Fang is active.

Publication


Featured researches published by Juanzhi Fang.


Journal of the Neurological Sciences | 2017

Early MRI results and odds of attaining ‘no evidence of disease activity’ status in MS patients treated with interferon β-1a in the EVIDENCE study

Patricia K. Coyle; Anthony T. Reder; Mark Freedman; Juanzhi Fang; Fernando Dangond


BMC Neurology | 2018

Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1

Anthony Traboulsee; David Li; Mark Cascione; Juanzhi Fang; Fernando Dangond; Aaron E. Miller


BMC Neurology | 2018

Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Anthony Traboulsee; David Li; Mark Cascione; Juanzhi Fang; Fernando Dangond; Aaron E. Miller


Neurology | 2016

Interferon β-1a SC tiw Reduces Mild to Moderate and Moderate to Severe Relapses and Disease Activity over 1 Year in Patients with Relapsing MS: Post Hoc Analyses of PRISMS Data (P3.036)

Aaron Boster; David Li; Eric Williamson; Juanzhi Fang; Fernando Dangond; Anthony Traboulsee


Neurology | 2016

Predictive Value of 6-Month T2 and Enhancing Lesions Among Patients with RRMS Receiving Interferon β-1a Subcutaneously Thrice Weekly or Placebo: Post Hoc Analyses of PRISMS Data (P1.401)

David Li; Regina Berkovich; Eric Williamson; Juanzhi Fang; Fernando Dangond; Anthony Traboulsee


Neurology | 2016

Predictive Value of Early MRI Measures for Long-Term Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis Receiving IFN β-1a SC tiw or IFN β-1a IM qw: Post Hoc Analyses of the EVIDENCE Study (P6.189)

Patricia K. Coyle; Mark Freedman; Fernando Dangond; Juanzhi Fang; Anthony T. Reder


Neurology | 2016

Association of Timing of Disease-Modifying Drug Treatment Initiation on Multiple Sclerosis Relapse Rates in Newly Diagnosed Patients (P3.118)

Amy L. Phillips; Juanzhi Fang; Frank Corvino; David Oliveri


Neurology | 2016

MRI Frequency and No Evidence of Disease Activity Status Among Patients with RRMS Receiving IFN β-1a SC tiw or IFN β-1a IM qw: Post Hoc Analyses of EVIDENCE (P6.190)

Anthony T. Reder; Mark Freedman; Juanzhi Fang; Fernando Dangond; Patricia K. Coyle


Neurology | 2015

Early Effects of Interferon Beta-1a SC tiw Versus Interferon Beta-1a IM qw on MRI Outcomes in Patients with Relapsing MS in the EVIDENCE Study (P7.257)

Anthony Reder; Mark Freedman; Juanzhi Fang; Ali Hassan; Choon Cha; Fernando Dangond; Patricia K. Coyle


Neurology | 2015

No Evidence of Disease Activity in Patients with Relapsing MS Treated with Interferon Beta-1a SC tiw versus Interferon Beta-1a IM qw: Subgroup Analyses of the EVIDENCE Study (P7.271)

Juanzhi Fang; Patricia K. Coyle; Ali Hassan; Choon Cha; Fernando Dangond; Anthony T. Reder; Mark Freedman

Collaboration


Dive into the Juanzhi Fang's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anthony Traboulsee

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

David Li

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Mark Freedman

Ottawa Hospital Research Institute

View shared research outputs
Top Co-Authors

Avatar

Aaron E. Miller

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eric Williamson

University of Pennsylvania

View shared research outputs
Researchain Logo
Decentralizing Knowledge